Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.09%||69.50||1.0%||$509.20m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.61%||205.06||1.9%||$451.31m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.60%||625.00||2.7%||$399.60m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.68%||4.21||0.7%||$294.29m|
|EXAS||EXACT Sciences Corp.||5.55%||80.84||18.0%||$141.11m|
|BMRN||BioMarin Pharmaceutical, Inc.||1.56%||84.24||4.2%||$134.04m|
BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The firm focuses on the treatment of rare diseases in which unmet medical needs exist and an enzyme in the biological pathway of the disease. Its programs include BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, a potential treatment for marburg virus disease and yellow fever. The company was founded in 1986 and is headquartered in Durham, NC.